Natalia Herrera-Vargas
Lima, LMA, Peru
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Implementation of a SARS-CoV-2 genomic surveillance network as a strategy to face other health challenges in Peru.
Journal: Revista peruana de medicina experimental y salud publica
Published: July 09, 2026
Dispersion of SARS-CoV-2 lineage BA.5.1.25 and its descendants in Peru during two COVID-19 waves in 2022.
Journal: Genomics & informatics
Published: July 31, 2023
Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates From Peru, 2018 and 2019.
Journal: Sexually transmitted diseases
Published: July 20, 2022
Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru.
Journal: PloS one
Published: April 28, 2022
Genomic surveillance of the Lambda SARS-CoV-2 variant in a global phylogenetic context.
Journal: Journal of medical virology
Published: April 12, 2022
Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections After a Second Wave With Predominance of Lambda in Lima and Callao, Peru.
Journal: Open forum infectious diseases
Published: January 12, 2022
SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence.
Journal: Lancet regional health. Americas
Published: September 15, 2021
Identification of the Gamma variant in an outbreak of COVID-19 at a prison in Peru.
Journal: Revista espanola de sanidad penitenciaria
Published: September 10, 2021
Genomic analysis reveals a rapid spread and predominance of lambda (C.37) SARS-COV-2 lineage in Peru despite circulation of variants of concern.
Journal: Journal of medical virology
Published: July 03, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026